Anti-LYST monoclonal antibody

Pre-made anti-LYST monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LYST/LYST products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2585-Ab-1/ GM-Tg-hg-IP2585-Ab-2Anti-Human LYST monoclonal antibodyHuman
GM-Tg-rg-IP2585-Ab-1/ GM-Tg-rg-IP2585-Ab-2Anti-Rat LYST monoclonal antibodyRat
GM-Tg-mg-IP2585-Ab-1/ GM-Tg-mg-IP2585-Ab-2Anti-Mouse LYST monoclonal antibodyMouse
GM-Tg-cynog-IP2585-Ab-1/ GM-Tg-cynog-IP2585-Ab-2Anti-Cynomolgus/ Rhesus macaque LYST monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2585-Ab-1/ GM-Tg-felg-IP2585-Ab-2Anti-Feline LYST monoclonal antibodyFeline
GM-Tg-cang-IP2585-Ab-1/ GM-Tg-cang-IP2585-Ab-2Anti-Canine LYST monoclonal antibodyCanine
GM-Tg-bovg-IP2585-Ab-1/ GM-Tg-bovg-IP2585-Ab-2Anti-Bovine LYST monoclonal antibodyBovine
GM-Tg-equg-IP2585-Ab-1/ GM-Tg-equg-IP2585-Ab-2Anti-Equine LYST monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2585-Ab-1/ GM-Tg-hg-IP2585-Ab-2; GM-Tg-rg-IP2585-Ab-1/ GM-Tg-rg-IP2585-Ab-2;
GM-Tg-mg-IP2585-Ab-1/ GM-Tg-mg-IP2585-Ab-2; GM-Tg-cynog-IP2585-Ab-1/ GM-Tg-cynog-IP2585-Ab-2;
GM-Tg-felg-IP2585-Ab-1/ GM-Tg-felg-IP2585-Ab-2; GM-Tg-cang-IP2585-Ab-1/ GM-Tg-cang-IP2585-Ab-2;
GM-Tg-bovg-IP2585-Ab-1/ GM-Tg-bovg-IP2585-Ab-2; GM-Tg-equg-IP2585-Ab-1/ GM-Tg-equg-IP2585-Ab-2
Products NameAnti-LYST monoclonal antibody
Formatmab
Target NameLYST
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LYST monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2585-Ag-1Recombinant multi-species LYST/ CHS/ CHS1 protein


    Target information

    Target IDGM-IP2585
    Target NameLYST
    Gene ID1130,17101,85419,718051,479195,101081414,281072,100050724
    Gene Symbol and Synonymsbeige,bg,CHS,CHS1,D13Sfk13,LYST,Mauve
    Uniprot AccessionQ99698,Q9TTK4
    Uniprot Entry NameLYST_HUMAN,LYST_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000143669
    Target ClassificationN/A

    The target: LYST, gene name: LYST, also named as CHS, CHS1. This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.